Hydroxychloroquine in the treatment of outpatients with mildly symptomatic COVID-19: a multi-center observational study

Ip, Andrew; Ahn, Jaeil; Zhou, Yizhao; Goy, André; Hansen, Eric; L. Pecora, Andrew; Sinclaire, Brittany; Bednarz, Urszula; Marafelias, Michael; S. Sawczuk, Ihor; P. Underwood, Joseph; M. Walker, David; S. PRASAD, R.; L. Sweeney, Robert; G. Ponce, Marie; La Capra, Samuel; J. Cunningham, Frank; Calise, Arthur; L. Pulver, Bradley; Ruocco, Dominic; E. Mojares, Greggory; P. Eagan, Michael; L. Ziontz, Kristy; Mastrokyriakos, Paul; L. Goldberg, Stuart

doi:10.1186/s12879-021-05773-w

Public

Hydroxychloroquine in the treatment of outpatients with mildly symptomatic COVID-19: a multi-center observational study

Published in BMC Infectious Diseases • Jan 14, 2021

Authors:

Andrew Ip

Jaeil Ahn

Yizhao Zhou

Abstract

BACKGROUND: Hydroxychloroquine has not been associated with improved survival among hospitalized COVID-19 patients in the majority of observational studies and similarly was not identified as an effective prophylaxis following exposure in a prospective randomized trial. We aimed to explore the role ...

Subject

Hydroxychloroquine

Coronavirus disease 2019 (COVID-19)

Observational study

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!